CorMedix Inc. SEC filings CRMD
CorMedix Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 24, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Proxy statement | Oct 14, 2025 | — |
| RW | Withdrawal request | Oct 7, 2025 | — |
| RW | Registration withdrawal request | Oct 6, 2025 | — |
| EFFECT | Filing | May 22, 2024 | — |
| CORRESP | Letter to the SEC | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 15, 2024 | — |
| EFFECT | Filing | Aug 20, 2021 | — |
| CORRESP | Letter to the SEC | Aug 18, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2021 | — |
| CERT | Filing | Feb 2, 2021 | — |
| 8-A12B | Filing | Feb 2, 2021 | — |
| 25 | Form 25 | Feb 1, 2021 | — |
| EFFECT | Filing | Nov 25, 2020 | — |
| CORRESP | Letter to the SEC | Nov 23, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2020 | — |
| CT ORDER | Filing | Dec 26, 2019 | — |
| EFFECT | Filing | Oct 23, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2018 | — |
| CORRESP | Letter to the SEC | Oct 22, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2018 | — |
| CORRESP | Letter to the SEC | Jul 11, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2018 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| EFFECT | Filing | Apr 16, 2018 | — |
| CORRESP | Letter to the SEC | Apr 11, 2018 | — |
| RW | Application for withdrawal of registration | Aug 25, 2017 | — |
| CT ORDER | Filing | May 15, 2017 | — |
| EFFECT | Filing | Jun 8, 2016 | — |
| EFFECT | Filing | Jun 6, 2016 | — |
| EFFECT | Filing | Jun 6, 2016 | — |
| EFFECT | Filing | Jun 6, 2016 | — |
| CORRESP | Letter to the SEC | Jun 6, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2016 | — |
| CT ORDER | Filing | Sep 15, 2015 | — |
| CT ORDER | Filing | Jul 24, 2015 | — |
| CT ORDER | Filing | Jul 24, 2015 | — |
| 25-NSE | Delisting notice | May 13, 2015 | — |
| EFFECT | Filing | Apr 17, 2015 | — |
| EFFECT | Filing | Mar 19, 2015 | — |
| EFFECT | Filing | Mar 19, 2015 | — |
| EFFECT | Filing | Feb 12, 2015 | — |
| CT ORDER | Filing | Feb 9, 2015 | — |
| NT 10-Q | Notice of late filing | Nov 14, 2013 | Sep 30, 2013 |
| EFFECT | Filing | Apr 4, 2013 | — |
| CORRESP | Letter to the SEC | Apr 4, 2013 | — |
| CORRESP | Letter to the SEC | Feb 22, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2013 | — |
| EFFECT | Filing | Jan 10, 2013 | — |
| D | Filing | Oct 3, 2012 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1410098
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.